Press Releases

  • BMBF joint project Ophthalmo-AI started / 2021

    Intelligent, cooperative support for diagnosis and therapy in ophthalmology

    Press Release / May 04, 2021

    © Heidelberg Engineering GmbH.

    Today’s imaging technologies in ophthalmology are so advanced that retinal and vascular structures in the eye can be resolved with unprecedented precision in two, three and even four dimensions. However, interpreting the image material and deriving a therapy decision taking into account the patient's history is a complex task that requires a lot of experience. Treatment errors may have severe consequences for patients. The recently launched joint project »Ophthalmo-AI«, coordinated by the Fraunhofer Institute for Biomedical Engineering IBMT, aims to create an intelligent and interactive assistance system that supports ophthalmologists with methods of explainable artificial intelligence to provide comprehensible diagnoses and treatment suggestions.

    more info
  • Fraunhofer IBMT collaborates in EC project for water saving solution for textile industry / 2021

    Waste2Fresh - Smart innovative system for recycling wastewater and creating closed loops in textile manufacturing industrial processes

    Press Release / April 14, 2021

    The Fraunhofer Institute for Biomedical Engineering IBMT, with it´s long-term expertise in nanotoxicity and nanosafety testing, contributes to a new EC project for water saving solutions for textile industry. This industry uses a vast amount of water for different steps in the textile dyeing process. It also produces a lot of wastewater, which contains a range of chemicals and dyes.

    more info
  • Fraunhofer IBMT expertise in the EU joint project EXTEND / 2021

    EXTEND - Overcoming neuromuscular deficits through innovative interface technologies

    Press Release / March 03, 2021

    Fraunhofer IBMT bidirectional microelectrodes help to reduce pathological tremor. The partners in the EU-funded project "EXTEND" are developing tools to create a minimally invasive neural interface platform to provide real-time bidirectional connectivity between a dense network of implanted wireless micro-stimulators and -sensors. These so-called Bidirectional Hyper-connected Neural Systems (BHNS) stimulate and record neuromuscular activity in a distributed and synchronized manner. Now the EXTEND researchers have shown that the BHNS approach can reduce essential tremor.

    more info
  • © Fraunhofer IBMT, Bernd Müller.

    The medical technology industry is facing major challenges due to digitalization, new manufacturing technologies and changes in the regulatory frame-work. In order to strengthen the innovative power of the SME-driven German medical technology industry, the BMBF joint project "EUREKA-AMeLie: New Advanced Systems Engineering Methods for Development Processes Using Product Examples from Medical Technology and Lifesciences", launched in October 2020, aims to create new opportunities for a structure for networked product development. Classical approaches and methods of systems engineer-ing along the V-model will be tested for their applicability with regard to new challenges and are interpreted and redeveloped in a contemporary way, taking into account work-science aspects.

    more info
  • Magnetoceuticals - Novel, patient-friendly approach to electromagnetic stimulation of nervous tissue / 2020

    Electrostimulation instead of medication

    Press Release / September 07, 2020

    Principle sketch of the "Magnetoceuticals" approach: Only a magnetic implant body  is implanted into the human body. The entire intelligence of the electronic  system is located in the extracorporeal, miniaturized electronics.
    © Fraunhofer IBMT.

    Today, a large number of diseases are treated with medication. This is often associated with side effects that can be serious for people who are already ill. A new therapeutic approach, known under the keyword "bioelectronic medicine", provides for the therapy of diseases by means of electrostimulation. Since April 2019, the Fraunhofer Institute for Biomedical Engineering IBMT has been contributing its many years of expertise in the field of intelligent miniaturized active implants to the BMBF joint project "Magnetoceuticals" to develop a novel electrostimulation system for nerve tissue.

    more info
  • EU project »SABYDOMA - SAfety BY Design Of nanoMAterials« / 2020

    SABYDOMA - Increasing safety of nanomaterials through accurate design

    Press Release / September 01, 2020

    The risks posed by nanomaterials to humans and the environment due to their very small size have not yet been fully clarified. For this reason, there is a need for new technologies that allow the risks posed to be identified and minimized even before they are industrially manufactured. This approach is embodied within the »Safety by Design« concept, which aims to minimize risks at an early stage of the design process. In addition to quality and efficacy, the safety of the product is also determined during the design phase. The EU project »SABYDOMA – SAfety BY Design Of nanoMAterials« develops new »Safety-by-Design« protocols and implements them in industrial processes.

    more info
  • ERA-NET project on translational research on cancer / 2020

    NExT – Earlier diagnosis of endocrine pancreatic tumors

    Press Release / August 20, 2020

    Since autumn 2019, the Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF-funded ERA-NET project "NExT" that aims to detect endocrine pancreatic tumors at an earlier stage and to improve therapies in cooperation with international research partners. The consortium is setting up a tissue bank, developing patient-specific cell-models and identifying corresponding biomarkers with the aid of a microfluidic chip system.

    more info
  • Human cell-based test systems for toxicity studies / 2020

    R2U-Tox-Assay - Ready-to-use Toxicity Screening Assay based on iPS-Technologies

    Press Release / August 05, 2020

    Since the beginning of 2020, the Fraunhofer Institute for Biomedical Engineering IBMT has been coordinating the "R2U-Tox-Assay" project, which is funded by EIT Health. The aim of this project is to develop innovative toxicity assays for drug research based on human cell systems. This should enable better prediction of undesired side effects of drug candidates in preclinical phases and reduce animal experiments in pharmaceutical research.

    more info
  • European scientists in the fight against cancer / 2020

    VISION - Strategies to strengthen scientific excellence and innovation in the early diagnosis of stomach and colon cancer

    Press Release / July 28, 2020

    Five European reserach institutions closely collaborate in the project „VISION“ to overcome existing gaps in oncology research and to reinforce the capacity for early diagnostics and innovative treatment approaches (Graphic designed by Freepik).

    The EU-funded project "VISION" is working on the early detection of cancer of the intestinal system. This is achieved through strategic partnerships with European specialists who improve the education of students and researchers in Slovakia and provide the latest technologies and expertise to strengthen research and treatment of gastrointestinal cancer in their own country.

    more info